loading page

Sarcoma with chondroid differentiation of the breast; a rare entity. About a case
  • +4
  • Jaime E. Cruz-López,
  • Rosa S. Reyna-Beltrán,
  • Angela Hernández-Rubio,
  • Erik E. Sosa-Durán,
  • Araceli N. Hernández-Rico,
  • Daniel Flores-Alatriste,
  • Xicotencatl Jiménez-Villanueva
Jaime E. Cruz-López
Hospital Juarez de Mexico

Corresponding Author:[email protected]

Author Profile
Rosa S. Reyna-Beltrán
Hospital Juarez de Mexico
Author Profile
Angela Hernández-Rubio
Hospital Juarez de Mexico
Author Profile
Erik E. Sosa-Durán
Hospital Juarez de Mexico
Author Profile
Araceli N. Hernández-Rico
Hospital Juarez de Mexico
Author Profile
Daniel Flores-Alatriste
Hospital Juarez de Mexico
Author Profile
Xicotencatl Jiménez-Villanueva
Hospital Juarez de Mexico
Author Profile

Abstract

Abstract Background: The primary breast sarcoma (PBS) was described in 1887. It was a generic term given to malignant breast tumors. The presentation of a sarcoma of the breast, it is a palpable, growing rapidly mass, with or without nipple discharge, or palpable axillary lymph nodes. The PBS can form masses up to 30cm in diameter. There are many risks factors for developing sarcoma of the breast. Clinical Case: A 57-year-old female presented with a 30 x 30cm tumor of the right breast, bleeding with necrosis of two years evolution. biopsy of the lesion is taken where moderately differentiated chondrogenic sarcoma is reported. Wide resection plus chest wall reconstruction (dorsal flap rotation plus partial thickness graft) was performed. A 45 x 40 cm right chest wall tumor is observed, intraoperative without palpable lymphadenopathy. She discharged from the hospital and continues to be monitored. Conclusion: Breast chondrosarcoma is rare and only a few cases are reported in the literature. The role of adjuvant therapy in these patients is still unclear due to the unusual nature of this tumor.
27 Aug 2023Submitted to Cancer Reports
29 Aug 2023Assigned to Editor
29 Aug 2023Submission Checks Completed
29 Aug 2023Review(s) Completed, Editorial Evaluation Pending
04 Sep 2023Reviewer(s) Assigned
06 Nov 2023Editorial Decision: Revise Major